Clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberCPMP/EWP/504/97 Rev. 1
Effective from01/04/2007
KeywordsAcute respiratory distress syndrome (ARDS)
DescriptionThis document provides guidance for the evaluation of new medicinal products for prevention and treatment of acute respiratory distress syndrome.

Document history

Revision 1

Current version

Adopted guideline

Overview of comments

In operation: 01/04/2007–present

Published: 21/09/2006

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more